Ampio Pharmaceuticals, Inc.
(NYSE Amex Equities : AMPE)

( )
AMPE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.13%53.920.9%$1395.93m
JNJJohnson & Johnson 0.85%180.990.7%$1263.76m
BMYBristol-Myers Squibb Co. -1.86%76.151.0%$1200.63m
MRKMerck & Co., Inc. 0.77%93.020.7%$1171.65m
ABBVAbbVie, Inc. -0.36%150.031.9%$1112.27m
LLYEli Lilly & Co. 3.15%323.341.1%$1017.85m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.15%143.400.0%$499.78m
AZNAstraZeneca Plc 1.05%67.401.0%$486.39m
NVSNovartis AG 0.22%91.460.2%$258.15m
GSKGlaxoSmithKline Plc -0.83%44.050.2%$255.09m
VERUVeru, Inc. 1.50%12.830.0%$252.54m
SIGASIGA Technologies, Inc. 41.91%13.680.0%$209.92m
HZNPHorizon Therapeutics Plc 4.69%94.845.4%$209.26m
SGENSeagen Inc. 2.12%141.395.7%$188.92m
NVONovo Nordisk A/S 1.07%107.740.1%$184.03m

Company Profile

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.